Richard H Woods
7
PUBLICATIONS
0
CO-AUTHORS
Pharmacology and pharmaceutical sciences not elsewhere classified
Obstetrics and gynaecology
Psychosocial aspects of childbirth and perinatal mental health
Dental therapeutics, pharmacology and toxicology
Medical infection agents (incl. prions)
Get your video featured.
Publish with JoVE
Get your video featured.
Publish with JoVE
Publications
(7)
Sort by Publication Date:
Latest
Clinical rheumatology
|
Jun 17, 2026
Disproportionality analysis of pyoderma gangrenosum reporting to the FDA Adverse Event Reporting System in association with antirheumatic biologics.
European journal of clinical pharmacology
|
Aug 18, 2025
Meningioma in users of progestogen contraceptives: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS).
Richard H Woods
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
|
Jun 14, 2024
Postmarketing Reports of Incomplete Dosing-Related Complications with Self-Injected PCSK9 Inhibitors: A Descriptive Study and Disproportionality Analysis.
Richard H Woods
American journal of perinatology
|
Apr 17, 2024
Equitable Representation of Pregnant and Lactating Women in Clinical Research: A Historical Review and Critical Analysis of Proposed Legislation.
Richard H Woods
Current drug safety
|
Aug 01, 2023
Dental Disorders Reported to the FDA Adverse Event Reporting System in Association with Buprenorphine: An Analysis by Ingredient Composition and Route of Administration.
Richard H Woods
British journal of clinical pharmacology
|
Nov 02, 2022
Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS).
Richard H Woods
Page
of 2
Frequent Collaborators
Frequent Collaborators
See all collaborators
Search research articles
Contact Us